Genetic Predisposition and Peptide Pathway Sensitivity Genetic variation in GLP-1 receptor signaling (GLP1R rs6923761), glucose-dependent insulinotropic polypeptide receptor pathways (GIPR rs1800437), and appetite regulation (MC4R rs17782313, FTO rs9939609) may influence individual dose tolerance and efficacy
Other intranasal preparations being explored in Parkinsons include dopamine, one using gene therapy, a vitamin E loaded naringenin, stem cells, glial cell-derived neurotrophic factor (GDNF), carnosine, BDNF, intranasal insulin, rotigotine, and estradiol
Initial intensive therapy (daily-weekly injections) typically lasts 1-2 months, followed by lifelong monthly maintenance for chronic conditions
In literature, the first report on catalase known as a monofunctional enzyme but possessing secondary activity (oxidase) was introduced for mammalian catalase
Antioxidant & Detox Genetics Do my genes give me a lower buffer against toxins or stress